Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07062887 · ClinicalTrials.gov registry record · NA

Digital Mindfulness for Young Adults With Type 1 Diabetes

A NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07062887 is a NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis that is actively recruiting participants, run by Yale University. The registered enrollment target is 10 participants, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07062887, a NA study of Type 1 Diabetes (T1D) and Diabetes Secondary to Pancreatitis, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All participants will receive mindfulness guidance and personalized feedback about the relationship among your mindfulness, blood sugar, stress, and sleep.

Interventions

  • BEHAVIORAL Mindfulness app

Study Locations (1)

Connecticut

  • Yale University School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-02-04
Est. Completion 2026-09
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT07062887

The ClinicalTrials.gov registry entry for NCT07062887 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (94% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness app is the first listed.

NCT07062887 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07062887 about?

NCT07062887 is a clinical study titled "Digital Mindfulness for Young Adults With Type 1 Diabetes". The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute insulin deficiency diabetes. Mindfulness is the practice of being aware of your thoughts and feelings in the moment without judgment or negative reaction. All ...

What is the current status of trial NCT07062887?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-02-04. Estimated completion is 2026-09.

What conditions does trial NCT07062887 study?

This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Diabetes Secondary to Pancreatitis.

What interventions are being tested in trial NCT07062887?

The interventions under investigation include: Mindfulness app (BEHAVIORAL).

Who is sponsoring clinical trial NCT07062887?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07062887 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes (T1D)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.